Kennedy's HHS appointment, Trump's DEA pick, new fast-track meds, and global cannabis trends—this week reshapes the future of ...
President Donald Trump has officially named his pick to lead the Drug Enforcement Administration (DEA)—selecting a ...
A federal appellate court has rejected the latest effort by a Washington State doctor who is seeking to legally use psilocybin to treat cancer patients in end-of-life care, ruling that the Drug ...
Robert F. Kennedy Jr., the new head of the U.S. Department of Health and Human Services ((HHS)) indicates mixed views on ...
Kennedy Jr. said cannabis needs to be closely studied in order to shape public health policies. In an interview on Fox News ...
A Drug Enforcement Administration (DEA) judge canceled an upcoming hearing on the Biden administration’s marijuana rescheduling proposal pending appeals, effectively kicking the process to the ...
The company contends that the DEA has obstructed domestic cannabis research despite the Right To Try and the Medical Marijuana Research Expansion Act. MMJ accuses the DEA of bias in restricting ...
The much-anticipated hearings on the proposed rulemaking to reschedule cannabis, which were scheduled to begin on January 21, ...
The legislation permanently reclassifies fentanyl as a Schedule I drug, meaning it has no accepted medical use and a high ...
President-elect Donald Trump on Tuesday nominated Terry Cole to lead the Drug Enforcement Administration, elevating a longtime law enforcement official who spent more than two decades at the agency ...